Read More 1 minute read Analyst Ratings News Price Target Reiteration Telsey Advisory Group Reiterates Outperform on Lulus Fashion Lounge, Maintains $9 Price Target By Benzinga Newsdesk March 7, 6:28 AM Telsey Advisory Group analyst Dana Telsey reiterates Lulus Fashion Lounge (NASDAQ:LVLU) with a Outperform and maintains $9 price target. LVLU
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on Stoke Therapeutics, Maintains $25 Price Target By Benzinga Newsdesk March 7, 5:52 AM Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $25 price target. STOK
Read More 1 minute read Analyst Ratings News Price Target Reiteration Piper Sandler Reiterates Neutral on Olo, Maintains $9 Price Target By Benzinga Newsdesk March 7, 5:48 AM Piper Sandler analyst Clarke Jeffries reiterates Olo (NYSE:OLO) with a Neutral and maintains $9 price target. OLO
Read More 1 minute read Analyst Ratings News Price Target Reiteration HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target By Benzinga Newsdesk March 7, 5:42 AM HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target. ARMP
Read More 2 minute read Analyst Color Analyst Ratings News Price Target Reiteration Tesla Loses ‘Top Pick’ Status: Analyst Backs This Luxury Carmaker As Best Positioned To Weather Challenges By Shanthi Rexaline March 7, 3:14 AM Tesla Inc. RACE
Read More 1 minute read Analyst Ratings News Price Target Reiteration Tech Trading Ideas HubSpot’s Launch Of ChatGPT Powered Tools Likely To Help Differentiate, Analyst Says By Anusuya Lahiri March 6, 3:59 PM Piper Sandler analyst Brent Bracelin reiterates HubSpot Inc (NYSE:HUBS) with an Overweight and $450 price target. On Monday, HubSpot launched two new… HUBS
Read More 2 minute read Analyst Color Analyst Ratings General News Price Target Reiteration Gap’s Q4 Could Prove More Challenging As Consumer Behavior Changes Post Holidays, Analyst Says By Shivani Kumaresan March 6, 1:23 PM GPS
Read More 1 minute read Analyst Ratings News Price Target Reiteration Small Cap Consumer Research Reiterates Buy on Build-A-Bear Workshop, Maintains $33 Price Target By Benzinga Newsdesk March 6, 12:23 PM Small Cap Consumer Research analyst Eric Beder reiterates Build-A-Bear Workshop (NYSE:BBW) with a Buy and maintains $33 price target. BBW
Read More 1 minute read Analyst Ratings News Price Target Reiteration EF Hutton Reiterates Buy on Adaptimmune Therapeutics, Maintains $10 Price Target By Benzinga Newsdesk March 6, 12:17 PM EF Hutton analyst Tony Butler reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $10 price target. ADAP
Read More 1 minute read Analyst Ratings News Price Target Reiteration Needham Reiterates Buy on CTI BioPharma, Maintains $9 Price Target By Benzinga Newsdesk March 6, 12:08 PM Needham analyst Gil Blum reiterates CTI BioPharma (NASDAQ:CTIC) with a Buy and maintains $9 price target. CTIC